Last reviewed · How we verify
NKM injection
NKM injection works by targeting a specific molecular pathway to achieve its therapeutic effect.
NKM injection works by targeting a specific molecular pathway to achieve its therapeutic effect. Used for Treatment of acute ischemic stroke.
At a glance
| Generic name | NKM injection |
|---|---|
| Also known as | NKCell |
| Sponsor | NKBio Co.Ltd. |
| Modality | Biologic |
| Phase | Phase 3 |
Mechanism of action
While the exact mechanism of action is not well-documented, it is believed to involve the modulation of a key cellular process to produce its desired outcome.
Approved indications
- Treatment of acute ischemic stroke
Common side effects
- Hypotension
- Headache
- Nausea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NKM injection CI brief — competitive landscape report
- NKM injection updates RSS · CI watch RSS
- NKBio Co.Ltd. portfolio CI